Evidence map›Paper›PMID 41463018›Full record

ArticleBiomedicines2025

Evolving Management Paradigms in Dural Arteriovenous Fistulas: From Classification to Personalized Endovascular Therapy.

Veena Shekar, Brandon Lucke-Wold

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Veena ShekarDepartment of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.ORCID 0009-0007-7672-2156
Brandon Lucke-WoldDepartment of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.ORCID 0000-0001-6577-4080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dural arteriovenous fistulas (dAVFs) represent a unique subset of intracranial vascular malformations characterized by pathologic shunting between dural arteries and venous sinuses or cortical veins. Although once considered rare and uniformly high-risk, modern imaging and therapeutic innovations have revealed a spectrum of biological behavior ranging from benign to aggressive. The past decade has witnessed a paradigm shift from purely anatomic classification toward individualized, hemodynamic-based decision-making that incorporates endovascular, microsurgical, and radiosurgical techniques. This Perspective reviews the evolving management of dAVFs, emphasizing early recognition of cortical venous drainage, endovascular innovation, venous sinus reconstruction, and the emerging role of artificial intelligence and personalized medicine in risk stratification. Accordingly, we seek to delineate how a precision approach based on angioarchitecture, patterns of venous flow, and clinical phenotype has transformed the treatment of dAVFs from a purely reactive to a potentially curative discipline.

Indexed as

cortical venous drainagedural arteriovenous fistulaembolizationendovascular therapyprecision medicinevenous sinus reconstruction

Identifiers

PMID41463018
PMCPMC12730843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.